Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vaccine Formulation Institute
Plan-les-Ouates, Geneva, Switzerland
- Ownership
- Private
- Development stage
- Other
01
Overview
VFI developed SWE, the first open-access adjuvant for prophylactic human vaccines since aluminum salts, now distributed commercially as Sepivac SWE and under clinical evaluation globally. VFI enables and supports preclinical to clinical vaccine programs through adjuvant technologies, but does not sponsor its own candidate vaccines.[1][2][4][9]
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- VaccineAdjuvantOil-in-water emulsionLiposomeMineral salt
- Industry
- Chemicals & Materials
02
Partnerships
Seppic (Air Liquide group, commercializing Sepivac SWE)[2][4]Bill & Melinda Gates Foundation[13]European Commission[12]National Institutes of Health (NIH)[12]Open Philanthropy[12]University of Geneva (academic partnership)[4]Biopôle, Lausanne (laboratory hosting)[4][9]TRANSVAC, ISIDORE (European vaccine infrastructure projects)[12]
Beyond the preview
Go deeper on Vaccine Formulation Institute.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vaccine Formulation Institute.